Dark

FLXN
Horizon Flexible Income ETF
stock BATS ETF

At Close

Sep 2, 2026 3:43:01 PM EDT

24.80USD+0.202%(+24.80)5,559

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD0.000%(0.00)0

After-hours

Sep 4, 2026 4:10:30 PM EDT

24.80USD-0.019%(0.00)3

Overview HistoricalExchangesShortsMore

open chart

Market Cap

1.25B

CEO

Michael Clayman

Headquarters

Burlington, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

JNJ PFE PCRX ACRX INSY AMPE REPH CARA XLV

FLXN Stats

Avg. Vol. 10 Day

14,105

Avg. Vol. 30 Day

48,393

Employees

257

Market Cap

1,248,439,200

Shares Out.

50,320,000

On/Off Exchange

5%/95%

6 Month Beta

0.33

1 Year Beta

0.31

2 Year Beta

0.31

3 Year Beta

1.00

52 Week Low

24.53

52 Week High

26.09

SMA50

24.88

SMA200

25.29

1 Week

+0.02%

1 Month

-0.25%

3 Month

-0.20%

6 Month

-2.44%

1 Year

-2.55%

2 Year

-1.08%

5 Year

+295.06%

Profile

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.

FLXN Stock Summary

Horizon Flexible Income ETF (BATS:FLXN) stock price today is $24.80, and today's volume is 5,559. FLXN is up 0.202% today. The 30 day average volume is 48,393. FLXN market cap is 1.25B with 50,320,000 shares outstanding.